Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 13Recruiting 7Unknown 6Active not recruiting 2Withdrawn 1Suspended 1Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Neoplasms 12Uterine Cervical Neoplasms 7Endometrial Neoplasms 6Colorectal Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Peritoneal Neoplasms 3Neoplasms 3Neoplasm Metastasis 3Breast Neoplasms 3Vulvar Neoplasms 2Triple Negative Breast Neoplasms 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Lung Neoplasms 2Fallopian Tube Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma, Ovarian Epithelial 2Vulvar Diseases 1Uterine Neoplasms 1Tissue Adhesions 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Ovarian Cysts 1Osteosarcoma 1Obesity 1Mesothelioma, Malignant 1Melanoma 1Malnutrition 1Lichen Sclerosus et Atrophicus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Endometriosis × Gynecologic × Clear all
NCT00865488 2009-12-23

Evaluation of Adhexil Safety and Efficacy in Prevention and/or Reduction of Adhesions in Gynecological Surgery

OMRIX Biopharmaceuticals

Phase 3 Suspended
80 enrolled
Gynecologic

Tissue Adhesions, Endometriosis, Ovarian Cysts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡